ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
ulcerative colitis, inflammatory bowel disease, gastrointestinal disease, colitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.